+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020-2027

  • ID: 5261879
  • Report
  • December 2020
  • Region: Global
  • 127 pages
  • Polaris Market Research

FEATURED COMPANIES

  • 3billion Inc.
  • Baylor Genetics
  • Color Genomics Inc.
  • Fulgent Genetics Inc.
  • Macrogen Inc.
  • Opko Health Inc.
  • MORE
The global rare disease genetic testing market size is expected to reach USD 1.8 Billion by 2027, according to the study.

The report “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020-2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing need for on-time diagnosis of uncommon disorders, rising prevalence of rare disorders, innovations in genomic testing, and the focused approach of the market player’s in cost-effective treatments are the key factors responsible for market growth. Moreover, government-sponsored schemes are also expected to positively impact the market. In February 2020, the government of India announced financial assistance of INR 15 lacs to the patients suffering from uncommon ailments under the Rashtriya Arogaya Nidhi scheme for a one-time treatment.

The global rare disease genetic testing industry is fragmented based on disease type, technology, specialty, end-use, and region. In terms of disease type, the market is segmented into neurological disorders, immunological disorders, hematology illnesses, endocrine & metabolism ailments, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology illnesses, and others.

Based on technology, the rare disease genetic testing industry is further bifurcated into next-generation sequencing, array technology, PCR-based testing, FISH, sanger sequencing, and karyotyping. Based on specialty, the rare disease genetic testing industry is further bifurcated into molecular, chromosomal, and biochemical genomic tests. Based on end-use, the rare disease genomic testing industry is further bifurcated into research laboratories & CROs, hospitals & clinics, and diagnostic laboratories.

Segment Highlights
  • Neurological ailments accounted for the largest revenue share in 2019 on account of the increasing prevalence of neurologic disorders across the globe and presence of numerous testing techniques.
  • Based on technology, the next generation sequencing segment is projected to constitute almost half of the market in 2027. The usage of the technology in whole genome sequencing is the key factor responsible for its segment’s growth.
  • Molecular tests are expected to account for the highest revenue share by the end of 2027. The availability of advanced technologies and ability to test ultra-rare disorders is expected to drive market growth.
  • Research laboratories & CROs accounted for the largest revenue share in 2019 owing to the increasing number of tests and growing occurrence of rare disorders across the developed economies.
List of Key Players
  • Strand Life Sciences
  • Myriad Genetics
  • Quest Diagnostics Inc.
  • Centogene N.V.
  • Invitae Corporation
  • Baylor Genetics
  • Ambry Genetics
  • Macrogen, Inc.
  • Opko Health, Inc.
  • Color Genomics, Inc.
  • Health Network Laboratories
  • Preventiongenetics, Progenity, Inc.
  • Fulgent Genetics Inc.
  • Others
The analyst has segmented the rare disease genetic testing market report on the basis of disease type, technology, specialty, end-use, and region.

Rare Disease Genetic Testing, Disease Type Outlook (Revenue-USD Million, 2016-2027)
  • Neurological Disorders
  • Immunological Disorders
  • Hematology Ailments
  • Endocrine & Metabolism Disorders
  • Cancer
  • Musculoskeletal Disorders
  • Cardiovascular Disorders
  • Dermatology Disorders
  • Others
Rare Disease Genetic Testing, Technology Outlook (Revenue-USD Million, 2016-2027)
  • Next Generation Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Array Technology
  • PCR-based Testing
  • FISH
  • Sanger Sequencing
  • Karyotyping
Rare Disease Genetic Testing, Specialty Outlook (Revenue-USD Million, 2016-2027)
  • Molecular Genetic Tests
  • Chromosomal Genetic Tests
  • Biochemical Genetic Tests
Rare Disease Genetic Testing, Technology Outlook (Revenue-USD Million, 2016-2027)
  • Research Laboratories & CROs
  • Hospitals & Clinics
  • Diagnostic Laboratories
Rare Disease Genetic Testing, Regional Outlook (Revenue-USD Million, 2016-2027)
  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Central & South America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3billion Inc.
  • Baylor Genetics
  • Color Genomics Inc.
  • Fulgent Genetics Inc.
  • Macrogen Inc.
  • Opko Health Inc.
  • MORE
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Rare Disease Genetic Testing Market Insights
4.1. Rare Disease Genetic Testing - Industry snapshot
4.2. Rare Disease Genetic Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Prevalence of rare diseases
4.2.1.2. Government backed funding
4.2.2. Restraints and Challenges
4.2.2.1. Lack of epidemiological data
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Rare Disease Genetic Testing Market Industry trends

5. Rare Disease Genetic Testing Market Assessment by Disease Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
5.3. Neurological Disorders
5.3.1. Global Rare Disease Genetic Testing Market, by Neurological Disorders, by Region, 2016- 2027 (USD Million)
5.4. Immunological Disorders
5.4.1. Global Rare Disease Genetic Testing Market, by Immunological Disorders, by Region, 2016- 2027 (USD Million)
5.5. Hematology Diseases
5.5.1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by Region, 2016- 2027 (USD Million)
5.6. Endocrine & Metabolism Diseases
5.6.1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism Diseases, by Region, 2016- 2027 (USD Million)
5.7. Cancer
5.7.1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2016- 2027 (USD Million)
5.8. Musculoskeletal Disorders
5.8.1. Global Rare Disease Genetic Testing Market, by Musculoskeletal Disorders, by Region, 2016- 2027 (USD Million)
5.9. Cardiovascular Disorders
5.9.1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders, by Region, 2016- 2027 (USD Million)
5.10. Dermatology Diseases
5.10.1. Global Rare Disease Genetic Testing Market, by Dermatology Diseases, by Region, 2016- 2027 (USD Million)
5.11. Other Rare Diseases
5.11.1. Global Rare Disease Genetic Testing Market, by Other Rare Diseases, by Region, 2016- 2027 (USD Million)

6. Global Rare Disease Genetic Testing Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
6.3. Next Generation Sequencing
6.3.1. Global Rare Disease Genetic Testing Market, by Next Generation Sequencing, By Region, 2016- 2027 (USD Million)
6.3.2. Whole Exome Sequencing
6.3.2.1. Whole Exome Sequencing Market, By Region, 2016- 2027 (USD Million)
6.3.3. Whole Genome Sequencing
6.3.3.1. Whole Genome Sequencing Market, By Region, 2016- 2027 (USD Million
6.4. Array Technology
6.4.1. Global Rare Disease Genetic Testing Market, by Array Technology, by Region, 2016- 2027 (USD Million)
6.5. PCR - based Testing
6.5.1. Global Rare Disease Genetic Testing Market, by PCR - based Testing, by Region, 2016- 2027 (USD Million)
6.6. FISH
6.6.1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2016- 2027 (USD Million)
6.7. Sanger Sequencing
6.7.1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by Region, 2016- 2027 (USD Million)
6.8. Karyotyping
6.8.1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region, 2016- 2027 (USD Million)

7. Global Rare Disease Genetic Testing Market, by Specialty
7.1. Key Findings
7.2. Introduction
7.2.1. Global Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
7.3. Molecular Genetic Testing
7.3.1. Global Rare Disease Genetic Testing Market, by Molecular, By Region, 2016- 2027 (USD Million)
7.4. Chromosomal Genetic Testing
7.4.1. Global Rare Disease Genetic Testing Market, by Chromosomal, by Region, 2016- 2027 (USD Million)
7.5. Biochemical Genetic Tests
7.5.1. Global Rare Disease Genetic Testing Market, by Biochemical Genetic Tests, by Region, 2016- 2027 (USD Million)

8. Rare Disease Genetic Testing Market Assessment by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
8.3. Research Laboratories & CROs
8.3.1. Global Rare Disease Genetic Testing Market, by Research Laboratories & CROs, by Region, 2016- 2027 (USD Million)
8.4. Hospitals & Clinics
8.4.1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by Region, 2016- 2027 (USD Million)
8.5. Diagnostic Laboratories
8.5.1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories, by Region, 2016- 2027 (USD Million)

9. Rare Disease Genetic Testing Market Assessment by Geography
9.1. Key findings
9.2. Introduction
9.2.1. Rare Disease Genetic Testing Market Assessment, By Geography, 2016- 2027 (USD Million)
9.3. Rare Disease Genetic Testing Market - North America
9.3.1. North America: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.3.2. North America: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.3.3. North America: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
9.3.4. North America: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.3.5. Rare Disease Genetic Testing Market - U.S.
9.3.5.1. U.S.: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.3.5.2. U.S.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.3.5.3. U.S.: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.3.5.4. U.S.: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.3.6. Rare Disease Genetic Testing Market - Canada
9.3.6.1. Canada: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.3.6.2. Canada.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.3.6.3. Canada: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.3.6.4. Canada: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4. Rare Disease Genetic Testing Market - Europe
9.4.1. Europe: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.2. Europe.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.3. Europe: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.4. Europe: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4.5. Rare Disease Genetic Testing Market - UK
9.4.5.1. UK: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.5.2. UK.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.5.3. UK: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.5.4. UK: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4.6. Rare Disease Genetic Testing Market - France
9.4.6.1. France: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.6.2. France.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.6.3. France: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.6.4. France: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4.7. Rare Disease Genetic Testing Market - Germany
9.4.7.1. Germany: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.7.2. Germany.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.7.3. Germany: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.7.4. Germany: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4.8. Rare Disease Genetic Testing Market - Italy
9.4.8.1. Italy: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.8.2. Italy.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.8.3. Italy: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.8.4. Italy: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4.9. Rare Disease Genetic Testing Market - Spain
9.4.9.1. Spain: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.9.2. Spain.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.9.3. Spain: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.9.4. Spain: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4.10. Rare Disease Genetic Testing Market - Netherlands
9.4.10.1. Netherlands: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.10.2. Netherlands.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.10.3. Netherlands: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.10.4. Netherlands: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.4.11. Rare Disease Genetic Testing Market - Austria
9.4.11.1. Austria: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.4.11.2. Austria.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.4.11.3. Austria: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.4.11.4. Austria: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.5. Rare Disease Genetic Testing Market - Asia-Pacific
9.5.1. Asia Pacific: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.5.2. Asia Pacific.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.5.3. Asia-pacific: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.5.4. Asia-pacific: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.5.5. Rare Disease Genetic Testing Market - China
9.5.5.1. China: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.5.5.2. China.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.5.5.3. China: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.5.5.4. China: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.5.6. Rare Disease Genetic Testing Market - India
9.5.6.1. India: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.5.6.2. India.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.5.6.3. India: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.5.6.4. India: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.5.7. Rare Disease Genetic Testing Market - Malaysia
9.5.7.1. Malaysia: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.5.7.2. Malaysia.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.5.7.3. Malaysia: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.5.7.4. Malaysia: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.5.8. Rare Disease Genetic Testing Market - Japan
9.5.8.1. Japan: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.5.8.2. Japan.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.5.8.3. Japan: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.5.8.4. Japan: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.5.9. Rare Disease Genetic Testing Market - Indonesia
9.5.9.1. Indonesia: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.5.9.2. Indonesia.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.5.9.3. Indonesia: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.5.9.4. Indonesia: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.5.10. Rare Disease Genetic Testing Market - South Korea
9.5.10.1. South Korea: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.5.10.2. South Korea.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.5.10.3. South Korea: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.5.10.4. South Korea: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.6. Rare Disease Genetic Testing Market - Middle East & Africa
9.6.1. Middle East & Africa: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.6.2. Middle East & Africa.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.6.3. Middle East & Africa: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.6.4. Middle East & Africa: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.6.5. Rare Disease Genetic Testing Market - Saudi Arabia
9.6.5.1. Saudi Arabia: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.6.5.2. Saudi Arabia.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.6.5.3. Saudi Arabia: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.6.5.4. Saudi Arabia: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.6.6. Rare Disease Genetic Testing Market - UAE
9.6.6.1. UAE: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.6.6.2. UAE.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.6.6.3. UAE: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.6.6.4. UAE: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.6.7. Rare Disease Genetic Testing Market - Israel
9.6.7.1. Israel: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.6.7.2. Israel.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.6.7.3. Israel: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.6.7.4. Israel: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.6.8. Rare Disease Genetic Testing Market - South Africa
9.6.8.1. South Africa: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.6.8.2. South Africa.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.6.8.3. South Africa: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.6.8.4. South Africa: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.7. Rare Disease Genetic Testing Market - Latin America
9.7.1. Latin America: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.7.2. Latin America.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.7.3. Latin America: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.7.4. Latin America: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.7.5. Rare Disease Genetic Testing Market - Mexico
9.7.5.1. Mexico: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.7.5.2. Mexico.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.7.5.3. Mexico: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.7.5.4. Mexico: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.7.6. Rare Disease Genetic Testing Market - Brazil
9.7.6.1. Brazil: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.7.6.2. Brazil.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.7.6.3. Brazil: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.7.6.4. Brazil: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
9.7.7. Rare Disease Genetic Testing Market - Argentina
9.7.7.1. Argentina: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
9.7.7.2. Argentina.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
9.7.7.3. Argentina: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
9.7.7.4. Argentina: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)

10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles
11.1. Strand Life Sciences
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Services/Product Benchmarking
11.1.4. Recent Developments
11.2. Myriad Genetics
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Services/Product Benchmarking
11.2.4. Recent Developments
11.3. Quest Diagnostics Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Services/Product Benchmarking
11.3.4. Recent Developments
11.4. Centogene N.V.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Services/Product Benchmarking
11.4.4. Recent Developments
11.5. Invitae Corporation
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Services/Product Benchmarking
11.5.4. Recent Developments
11.6. Eurofins Scientific
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Services/Product Benchmarking
11.6.4. Recent Developments
11.7. Ambry Genetics
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Services/Product Benchmarking
11.7.4. Recent Developments
11.8. Macrogen, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Services/Product Benchmarking
11.8.4. Recent Developments
11.9. Health Network Laboratories
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Services/Product Benchmarking
11.9.4. Recent Developments
11.10. Fulgent Genetics Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Services/Product Benchmarking
11.10.4. Recent Developments
Note: Product cover images may vary from those shown
  • Strand Life Sciences
  • Myriad Genetics
  • Quest Diagnostics Inc.
  • Centogene N.V.
  • Invitae Corporation
  • 3billion Inc.
  • Eurofins Scientific
  • Baylor Genetics
  • Ambry Genetics
  • Perkin Elmer
  • Macrogen Inc.
  • Opko Health Inc.
  • Color Genomics Inc.
  • Health Network Laboratories
  • Preventiongenetics
  • Progenity Inc.
  • Fulgent Genetics Inc.
  • Laboratory Corporation of America Holdings
Note: Product cover images may vary from those shown
Adroll
adroll